Faraday Future Intelligent Electric Aktie

Faraday Future invested about $41 million in Qualigen Therapeutics in a PIPE, acquiring roughly 55% of the pro-forma common equity. Faraday contributed around $30 million, founder and co-CEO YT Jia invested an additional $4 million and secured about 7% with a two-year lock-up. The transaction includes other investors such as the SIGN Foundation; Qualigen plans to rebrand as CXC10 and refocus on Web3 and crypto business areas. » More on de.investing.com

Faraday Future has completed a strategic $41 million investment in Qualigen, acquiring roughly 55% of the pro forma common shares. Faraday led the transaction with about $30 million; founder and co‑CEO YT Jia invested an additional $4 million and receives roughly 7% with a two‑year lock‑up. Qualigen is expected to be renamed CXC10 and to shift more toward crypto/Web3. Analysts simultaneously point to high cash burn and weak liquidity metrics, but forecast strong revenue growth for the current year. » More on de.investing.com

Faraday Future announces a strategic investment of about $30 million in Qualigen and would, on a pro forma basis, acquire roughly 55% of the common shares. Upon closing, Qualigen is to be renamed CXC10 and refocused on crypto- and Web3-related activities; FF founder YT Jia will invest an additional roughly $4 million and would hold just under 7%. Faraday Future plans personnel changes for the new initiatives (Jerry Wang named as a possible co-CEO) and receives nomination rights for several board seats. At the same time, the company released product updates for the MPV model FX Super One and reported an adjusted operating loss of about $27.4 million for Q2 2025, while its liquidity position improved. » More on de.investing.com